Chalfont St. Giles, UK and Songdo, Korea – 29 September 2016 – GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries, announced today the opening of a GE Fast Trak Center in Songdo, Incheon Metropolitan City, South Korea. The new USD 7.4 million Center will... Read more
Rome – 22 September 2016 – GE Healthcare and Trice Imaging, Inc., a cloud-based medical imaging solutions provider, today announced a commercial partnership to provide a new way for clinicians to connect with their colleagues and patients. This solution – called Tricefy™ – adds cloud-based image sharing, diagnostic collaboration, remote reviewing, archiving and Electronic Health Record... Read more
CHALFONT ST. GILES, UK and YAROSLAVL, RUSSIA – 22 September 2016 – R-Pharm Group has opened an innovative biopharmaceutical production plant equipped with GE Healthcare’s FlexFactory™ manufacturing platform in Yaroslavl, Russia. R-Pharm’s FlexFactory will support the mass production of biologics and biosimilars focused on treating autoimmune diseases and cancer, and allowing for increased access to these... Read more
CORK – 19 September, 2016 – Ireland’s Minister for Jobs, Enterprise and Innovation, Mary Mitchell O’Connor TD, today announced that GE (NYSE:GE) is to invest €150 million in a new biopharmaceutical manufacturing campus on Industrial Development Agency (IDA) Ireland’s strategic site at Loughbeg, Ringaskiddy, Co. Cork. GE BioPark Cork, subject to contract and planning approvals,... Read more
Metrohm is pleased to present «Pharmaceutical analysis», a dedicated online resource providing an overview of the most important methods and applications for the determination of active ingredients, excipients, and impurities in pharmaceuticals. «Pharmaceutical analysis» draws on Metrohm’s comprehensive expertise in chemical analysis for the quality control of pharmaceuticals. Using the U.S. Pharmacopeia as a reference,... Read more
CHALFONT ST. GILES, UK and CHARLOTTE, NC – 17 August 2016 – GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries and Sealed Air Corporation, a global manufacturer of primary films for pharmaceutical solutions, today announced the expansion of a strategic alliance designed to further... Read more
We are making the chemical engineer’s life a bit more comfortable: A new section on the Metrohm website takes a comprehensive look at the methods and applications used in the quality control of the industrial manufacturing of basic chemicals, solvents, colorants, and their intermediates. Whether you are looking for a specific parameter and suitable methods... Read more
VENLO, The Netherlands, July 23 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) today announced that its offer to exchange cash and stock for all outstanding shares of Digene Corporation (Nasdaq: DIGE) expired as scheduled at 11:59 p.m., New York City time, on Friday, July 20, 2007. All conditions of the exchange offer... Read more
Takara Bio enters into a license and supply agreement of RetroNectin® with Kite Pharma Kusatsu/Shiga, Japan — June 21, 2016 – Takara Bio Inc. announces that it has entered into a License and Supply Agreement with Kite Pharma, Inc. (“Kite”), United States, under which Takara Bio grants Kite a commercial license to use applicable patents relating... Read more
CHALFONT ST. GILES, UK – 13 June 2016 – GE Healthcare’s Life Sciences business today launched the first of a next generation of BiacoreTM systems harnessing Surface Plasmon Resonance (SPR) technology. Biacore 8K marks the start of a new generation of Biacore systems maintaining the high data quality expected from Biacore at high throughput. New... Read more